Literature DB >> 21398411

Analysis of significant factors influencing visual acuity in ocular syphilis.

Konstantinos Balaskas1, Theodoros N Sergentanis, Stefano Giulieri, Yan Guex-Crosier.   

Abstract

BACKGROUND: The aim of this study is to determine whether statistical associations can be demonstrated in ocular syphilis between baseline clinical and laboratory parameters with visual acuity at presentation and with any change in visual acuity after treatment.
METHODS: Charts of 26 patients (42 eyes) with ocular syphilis presenting to the Uveitis clinic of the Jules-Gonin Eye Hospital were reviewed. A baseline cross-sectional analysis was performed in order to identify any association between visual acuity at presentation and demographic, clinical or laboratory parameters. After treatment, any analogy between these parameters and a change in visual acuity was subsequently assessed in a series of univariate comparisons.
RESULTS: The following factors were associated with worse initial visual acuity: severity of visual field impairment at presentation (p=0.012), macular oedema (p=0.004) and optic neuropathy (p=0.031). There was a borderline association with the presence of vasculitis on fluroangiography (p=0.072). Improvement in best corrected visual acuity after treatment was significantly associated with the presence of vasculitis on fluroangiography (p=0.005), neurosyphilis, according to lumbar puncture findings (p=0.037) and marginally with anterior uveitis (p=0.070). Inflammation relapse was associated with the coexistence of pain as presenting sign (p<0.001) and with a longer duration of symptoms prior to the initial visit (p=0.023).
CONCLUSIONS: Severe ocular inflammation associated with vasculitis, vitritis or anterior uveitis in ocular syphilis would appear to be a reversible phenomenon that responds well to appropriate antibiotic treatment, resulting in improvement in visual acuity. Prompt treatment enables a good visual prognosis, while any delay in therapy increases the risk of subsequent relapse.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398411     DOI: 10.1136/bjo.2010.194498

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Ocular syphilis: the re-establishment of an old disease.

Authors:  J Wells; C Wood; A Sukthankar; N P Jones
Journal:  Eye (Lond)       Date:  2017-08-04       Impact factor: 3.775

Review 2.  Neurosyphilis: Knowledge Gaps and Controversies.

Authors:  Susan Tuddenham; Khalil G Ghanem
Journal:  Sex Transm Dis       Date:  2018-03       Impact factor: 2.830

3.  Fluorescein and indocyanine-green angiography in ocular syphilis: an exploratory study.

Authors:  Konstantinos Balaskas; Theodoros N Sergentanis; Stefano Giulieri; Yan Guex-Crosier
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-25       Impact factor: 3.117

4.  OCULAR SYPHILIS IN A KIDNEY TRANSPLANT RECIPIENT.

Authors:  Elen A Romao; Valdes R Bolella; Maria Estela P Nardin; Maria Lucia Habib-Simao; João Marcelo Furtado; Miguel Moyses-Neto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-05-24       Impact factor: 1.846

5.  Ocular syphilis: opportunities to address important unanswered questions.

Authors:  Susan Tuddenham; Khalil G Ghanem
Journal:  Sex Transm Infect       Date:  2016-04-26       Impact factor: 3.519

Review 6.  Clinical Features and Treatments of Syphilitic Uveitis: A Systematic Review and Meta-Analysis.

Authors:  Ting Zhang; Ying Zhu; Gezhi Xu
Journal:  J Ophthalmol       Date:  2017-06-29       Impact factor: 1.909

7.  Intravitreal sustained-release dexamethasone implant for the treatment of persistent cystoid macular edema in ocular syphilis.

Authors:  Parthopratim Dutta Majumder; Lakshmi Mayilvakanam; Amit H Palker; Sudharshan Sridharan; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2019-09       Impact factor: 1.848

8.  Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy.

Authors:  Sridharan Sudharshan; Nitin K Menia; Poongulali Selvamuthu; Mudit Tyagi; N Kumarasamy; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

9.  Clinical Manifestations and Treatment Outcomes of Syphilitic Uveitis in a Chinese Population.

Authors:  Rui Zhang; Jiang Qian; Jie Guo; Yifei Yuan; Kang Xue; Han Yue; Ling Chen
Journal:  J Ophthalmol       Date:  2016-04-10       Impact factor: 1.909

10.  Clinical Manifestations and Ophthalmic Outcomes of Ocular Syphilis at a Time of Re-Emergence of the Systemic Infection.

Authors:  João M Furtado; Tiago E Arantes; Heloisa Nascimento; Daniel V Vasconcelos-Santos; Natalia Nogueira; Rafael de Pinho Queiroz; Luana P Brandão; Thaís Bastos; Ricardo Martinelli; Rodrigo C Santana; Cristina Muccioli; Rubens Belfort; Justine R Smith
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.